Financial Benefits of

Theralase® Low-Level Laser Therapy (LLLT)


Return on Investment (ROI)

Everyone benefits from using the Theralase® laser system; your patient gets better through safe and effective treatments, while your practice generates increased revenue. 


Theralase® is more affordable than ever for US practitioners and patients. With Current Procedural Terminology (CPT) codes assigned by the American Medical Association, the Theralase®reimbursement strategy allows practitioners and patients to claim cold laser treatments through public health insurance programs, as well as private programs.

Public Reimbursement

Theralase® treatments are reimbursable through public insurance in the United States Average cost per treatment with public reimbursement is between $0 and $40. The total level of reimbursement is dependant on third party insurer and state.

Private Reimbursement

With private insurance programs (paid for by the patient) the average cost is between $40 and $100 per treatment. The overall cost of treatment is largely dependant on practitioner qualifications and proximity to urban centers.

Partnering to Grow Your Practice

In addition to providing you our latest cutting-edge technology, Theralase® will partner with you to help you deliver superior treatment outcomes for your patients and grow your business.

   Training for all clinic staff

   Technical support by Internet remote access

   Full coverage product warranty

   Software updates and upgrades

   Updates to programmed treatment protocols based on actual treatment data derived from Theralase® systems worldwide